Clinical Trial

Tolerance Profile of Soluble Fibers in Individuals With Self-perceived GI Sensitivity to Fibers (Tarine)

Study acronym: Tarine
Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine the optimal dose of soluble fibers that induces tolerable gastrointestinal symptoms.
Protocol Amendment History 4 changes
critical Trial completed 2026-06-17
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-15
notable Enrollment reduced: 173 -> 141 participants 2026-05-15
minor Completion pushed: 2026-05 -> 2026-06 2026-05-15
Trial Details
NCT Number NCT06877013
Lead Sponsor Danone Global Research & Innovation Center
Conditions Population With Self-perceived Gastro-intestinal Sensitivity to Fibers
Enrollment 141 participants
Start Date 2025-11-13
Primary Completion 2026-05-06 (estimated)
Study Completion 2026-06-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-16